Rockwell Medical, Inc., together with its subsidiaries, operates as a biopharmaceutical company that targets end-stage renal disease and chronic kidney disease with therapies and products for the treatment of iron deficiency and hemodialysis in the United States and internationally. The company offers Triferic Dialysate and Triferic AVNU, an iron therapy that replaces iron and maintains hemoglobin in dialysis patients without increasing iron stores. It also manufactures, sells, delivers, and distributes hemodialysis concentrates, such as CitraPure citric acid concentrate, Dri-Sate dry acid concentrate, RenalPure liquid acid concentrate, dry acid concentrate mixer, and RenalPure and SteriLyte powder bicarbonate concentrate; and ancillary products, including blood tubing, fistula needles, dialyzers, drugs, specialized component kits, dressings, cleaning agents, filtration salts, and other supplies used by hemodialysis providers. The company's dialysis concentrate products are used to maintain human life by removing toxins and replacing critical nutrients in the dialysis patient's bloodstream. It is also developing other therapeutic product candidates for the treatment of hospitalized patients with acute heart failure; and home infusion therapy that allows patients to receive intravenous medications at home. Its target customers include medium and small sized dialysis chains and independent dialysis centers. Rockwell Medical, Inc. was incorporated in 1996 and is headquartered in Wixom, Michigan.
Over the last 12 months, insiders at Rockwell Medical, Inc. have bought $0 and sold $0 worth of Rockwell Medical, Inc. stock.
On average, over the past 5 years, insiders at Rockwell Medical, Inc. have bought $315,891 and sold $440,718 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 24,681 shares for transaction amount of $47,563 was made by Richmond David S. (10 percent owner) on 2020‑06‑30.
2020-12-21 | Sale | Richmond David S. | 10 percent owner | 42,450 0.0609% | $1.03 | $43,724 | -13.00% | |
2020-12-16 | Sale | Richmond David S. | 10 percent owner | 521,876 0.7092% | $1.01 | $529,649 | -15.87% | |
2020-12-15 | Sale | Richmond David S. | 10 percent owner | 278,124 0.3947% | $1.11 | $307,505 | -19.27% | |
2020-06-30 | Richmond David S. | 10 percent owner | 24,681 0.034% | $1.93 | $47,563 | -43.33% | ||
2020-05-14 | ELLISON RUSSELL H | See Remarks | 2,000 0.003% | $2.08 | $4,160 | -38.50% | ||
2019-08-02 | Richmond David S. | 10 percent owner | 97 0.0002% | $2.42 | $235 | -5.31% | ||
2019-07-31 | Richmond David S. | 10 percent owner | 1,807 0.0028% | $2.66 | $4,806 | -12.78% | ||
2019-07-29 | Sale | Richmond Brothers, Inc. | director | 179 0.0003% | $3.12 | $558 | -25.64% | |
2019-07-25 | Richmond David S. | 10 percent owner | 319 0.0005% | $3.06 | $976 | -23.61% | ||
2019-07-24 | Richmond David S. | 10 percent owner | 2,579 0.004% | $3.13 | $8,072 | -25.80% | ||
2019-07-22 | Richmond David S. | 10 percent owner | 92,707 0.1463% | $2.99 | $277,194 | -20.88% | ||
2019-07-19 | Richmond David S. | 10 percent owner | 68,750 0.1031% | $2.89 | $198,688 | -21.85% | ||
2019-07-08 | Richmond David S. | 10 percent owner | 9,780 0.0154% | $3.05 | $29,788 | -21.12% | ||
2019-07-01 | Paul Stuart M | Chief Executive Officer | 10,000 0.0156% | $2.97 | $29,700 | -20.07% | ||
2019-06-28 | Smith Angus W. | Chief Financial Officer | 10,000 0.0175% | $3.06 | $30,600 | -20.27% | ||
2019-05-09 | Richmond David S. | 10 percent owner | 4,643 0.0081% | $5.65 | $26,211 | -55.48% | ||
2019-03-27 | Richmond David S. | 10 percent owner | 5,869 0.0103% | $5.59 | $32,788 | -52.06% | ||
2018-10-15 | Richmond David S. | 10 percent owner | 5.54M 50.7095% | $22.00 | $121.91M | -22.84% | ||
2018-06-28 | Richmond David S. | 10 percent owner | 7,940 0.0154% | $4.37 | $34,726 | -3.40% | ||
2018-06-27 | Richmond David S. | 10 percent owner | 4,621 0.0094% | $4.73 | $21,857 | -5.53% |
CHIOINI ROBERT L | Chairman, President and CEO | 1793933 6.2968% | $1.74 | 2 | 9 | <0.0001% |
Richmond David S. | 10 percent owner | 1433309 5.031% | $1.74 | 16 | 4 | <0.0001% |
HAGELSTEIN DAVID A | 10 percent owner | 1360700 4.7761% | $1.74 | 34 | 4 | +6.89% |
Paul Stuart M | Chief Executive Officer | 363798 1.2769% | $1.74 | 1 | 0 | <0.0001% |
Gupta Ajay | Chief Scientific Officer | 326667 1.1466% | $1.74 | 1 | 0 | <0.0001% |
KLEMA THOMAS E | Vice President, CFO | 232526 0.8162% | $1.74 | 0 | 1 | |
Smith Angus W. | Chief Financial Officer | 176667 0.6201% | $1.74 | 1 | 0 | <0.0001% |
Richmond Brothers, Inc. | director | 161278 0.5661% | $1.74 | 0 | 1 | |
Pratt Raymond Dennis | VP of Drug Development | 160700 0.5641% | $1.74 | 1 | 0 | <0.0001% |
BOYD RONALD D | director | 32500 0.1141% | $1.74 | 0 | 13 | |
HOLT KENNETH L | director | 12630 0.0443% | $1.74 | 0 | 45 | |
ELLISON RUSSELL H | See Remarks | 12050 0.0423% | $1.74 | 1 | 0 | <0.0001% |
Armistice Capital Llc | $4.37M | 8.67 | 2.63M | +41.99% | +$1.29M | 0.05 | |
The Vanguard Group | $1.86M | 3.69 | 1.12M | +4.03% | +$71,881.33 | <0.0001 | |
Perkins Capital Management Inc | $579,000.00 | 1.15 | 348,684 | -0.36% | -$2,075.66 | 0.5 | |
Richmond Brothers, Inc. | $534,950.00 | 1.06 | 322,251 | -21.87% | -$149,705.85 | 1 | |
Geode Capital Management | $479,464.00 | 0.95 | 288,760 | +1.7% | +$8,031.47 | <0.0001 | |
BlackRock | $294,638.00 | 0.59 | 177,493 | -0.4% | -$1,175.28 | <0.0001 | |
Marshall Wace | $162,395.00 | 0.32 | 97,828 | -44.13% | -$128,265.29 | <0.0001 | |
State Street | $123,345.00 | 0.25 | 74,304 | 0% | +$0 | <0.0001 | |
Northern Trust | $105,971.00 | 0.21 | 63,838 | 0% | +$0 | <0.0001 | |
Citadel Advisors LLC | $94,620.00 | 0.19 | 57,000 | +139.08% | +$55,043.94 | <0.0001 | |
Squarepoint Ops LLC | $94,602.00 | 0.19 | 56,989 | +132.4% | +$53,895.37 | <0.0001 | |
Hightower Advisors | $54,000.00 | 0.11 | 32,698 | 0% | +$0 | <0.0001 | |
Xtx Topco Ltd | $53,791.00 | 0.11 | 32,404 | New | +$53,791.00 | <0.01 | |
Wealthtrust Axiom Llc | $52,290.00 | 0.1 | 31,500 | 0% | +$0 | 0.02 | |
Susquehanna International Group | $37,677.00 | 0.08 | 22,697 | -54.27% | -$44,712.08 | <0.0001 | |
Morgan Stanley | $29,268.00 | 0.06 | 17,631 | -33.38% | -$14,661.39 | <0.0001 | |
Cetera Advisor Networks LLC | $23,451.00 | 0.05 | 14,127 | 0% | +$0 | <0.0001 | |
Renaissance Technologies | $17,000.00 | 0.04 | 10,511 | -89.3% | -$141,824.09 | <0.0001 | |
Tower Research Capital | $7,699.00 | 0.02 | 4,638 | +72.61% | +$3,238.63 | <0.0001 | |
UBS | $5,156.00 | 0.01 | 3,106 | +3,351.11% | +$5,006.60 | <0.0001 | |
Bank of America | $3,303.00 | 0.01 | 1,990 | 0% | +$0 | <0.0001 | |
Wells Fargo | $1,349.00 | <0.01 | 813 | +0.49% | +$6.64 | <0.0001 | |
Advisor Group Holdings Inc | $1,067.00 | <0.01 | 643 | -79.97% | -$4,261.36 | <0.0001 | |
Group One Trading | $478.00 | <0.01 | 288 | New | +$478.00 | <0.0001 | |
Rise Advisors Llc | $357.00 | <0.01 | 215 | 0% | +$0 | <0.0001 | |
Allworth Financial Lp | $469.00 | <0.01 | 282 | New | +$469.00 | <0.0001 | |
Comerica | $271.00 | <0.01 | 163 | 0% | +$0 | <0.0001 | |
Ogorek Anthony Joseph Ny Adv | $0 | <0.01 | 226 | 0% | +$0 | <0.0001 | |
Royal Bank of Canada | $0 | <0.01 | 29 | -74.78% | -$0 | <0.0001 | |
Old Point Trust & Financial Service | $149.00 | <0.01 | 90 | New | +$149.00 | <0.0001 | |
JPMorgan Chase | $58.00 | <0.01 | 35 | 0% | +$0 | <0.0001 |